Aims: To define the mechanisms underlying pyrazole-induced oxidative stress and the protective role of peroxiredoxins (Prxs) and sulfiredoxin (Srx) against such stress. Results: Pyrazole increased Srx expression in the liver of mice in a nuclear factor erythroid 2-related factor 2 (Nrf2)-dependent manner and induced Srx translocation from the cytosol to the endoplasmic reticulum (ER) and mitochondria. Pyrazole also induced the expression of CYP2E1, a primary reactive oxygen species (ROS) source for ethanol-induced liver injury, in ER and mitochondria. However, increased CYP2E1 levels only partially accounted for the pyrazole-mediated induction of Srx, prompting the investigation of CYP2E1-independent ROS generation downstream of pyrazole. Indeed, pyrazole increased ER stress, which is known to elevate mitochondrial ROS. In addition, pyrazole upregulated CYP2E1 to a greater extent in mitochondria than in ER. Accordingly, among Prxs I to IV, PrxIII, which is localized to mitochondria, was preferentially hyperoxidized in the liver of pyrazole-treated mice. Pyrazoleinduced oxidative damage to the liver was greater in PrxIII -/ -mice than in wild-type mice. Such damage was also increased in Srx -/ -mice treated with pyrazole, underscoring the role of Srx as the guardian of PrxIII. Innovation: The roles of Prxs, Srx, and ER stress have not been previously studied in relation to pyrazole toxicity. Conclusion: The concerted action of PrxIII and Srx is important for protection against pyrazole-induced oxidative stress arising from the convergent induction of CYP2E1-derived and ER stress-derived ROS in mitochondria. Antioxid. Redox Signal. 00, 000-000.
Introduction
T he hepatotoxin pyrazole is a substrate of cytochrome P450 2E1 (CYP2E1). Similar to many other substrates for CYP2E1, pyrazole increases the expression of this enzyme at the level of protein stabilization (32) . Such up-regulation of CYP2E1 results in oxidative stress, because electron transfer from the donor system to CYP2E1 is not perfectly coupled and is, therefore, leaky (27, 30) , and the leaked electrons react with O 2 to produce reactive oxygen species (ROS). CYP2E1 is a major ROS producer that plays a central role in the pathogenesis of alcoholic liver injury (17, 20) . Pyrazole has been widely used as an inducer of CYP2E1 in studies of CYP2E1-dependent oxidative stress and liver injury (21, 38, 39) . Although CYP2E1 is predominantly localized to the endoplasmic reticulum (ER) (19) , it is also present in mitochondria of the liver (1, 4, 24, 29) . Pyrazole increases the abundance of CYP2E1 in both the ER and mitochondria of the rat liver (4, 29, 35) .
Peroxiredoxins (Prxs) catalyze the reduction of ROS, with a catalytic cysteine (Cys) residue serving as the site of oxidation
Innovation
Pyrazole has been widely used as an inducer of CYP2E1 in studies of CYP2E1-dependent oxidative stress and liver injury. 2-cysteine peroxiredoxins (Prxs) (PrxI to IV) inevitably undergo hyperoxidation during the elimination of reactive oxygen species (ROS). Taking advantage of the fact that Prx isoforms reside in different subcellular compartments, the extent of hyperoxidation of each Prx isoform was measured to define the localization of ROS production. Here, we found that PrxIII, which is specifically localized to mitochondria, was preferentially hyperoxidized in the liver in response to exposure to pyrazole. This is likely because pyrazole increases CYP2E1 abundance to a greater extent in mitochondria than in the endoplasmic reticulum (ER) and because it induces ER stress that results in increased Ca 2 + and ROS levels in mitochondria. Using mice lacking either PrxIII or sulfiredoxin, the pivotal function of the two enzymes in mitigating hepatotoxicity in pyrazole-treated mice was demonstrated.
by peroxides (28) . The six mammalian Prx isoforms (PrxI to VI) show distinct subcellular distributions (12, 18, 28, 34) . PrxI is located in the cytosol, in the plasma membrane, and at the cytosolic side of the ER membrane; PrxII and PrxVI are predominantly localized in the cytosol; PrxIV is restricted to the ER lumen; PrxV is present in the cytosol, mitochondria, and peroxisomes; and PrxIII is synthesized with a mitochondrial targeting sequence and is exclusively localized in the mitochondria. PrxI to PrxIV, the four members of the 2-Cys Prx subgroup, exist as homodimers and possess two conserved Cys residues. In the catalytic cycle of 2-Cys Prxs, peroxides oxidize the sulfhydryl group of the NH 2 -terminal conserved Cys (designated the peroxidatic Cys, or C P -SH) to Cys sulfenic acid (Cys-SOH), which then reacts with the COOHterminal conserved Cys-SH (the resolving Cys, C R -SH) of the other subunit in the homodimer to form a disulfide. The resulting disulfide is subsequently reduced by thioredoxin to complete the catalytic cycle. As a result of the slow rate of its reaction with C R -SH, C P -SOH is occasionally further oxidized to Cys sulfinic acid (Cys-SO 2 H) (26, 40) . This hyperoxidation reaction, which results in the inactivation of peroxidase function, is reversed by the ATP-dependent enzyme sulfiredoxin (Srx) (6, 36, 37) .
We previously showed that chronic ethanol consumption in mice results in the hyperoxidation of PrxI, but not that of the other 2-Cys Prxs, in the liver (2) . This specific inactivation of PrxI was due to the colocalization of a large proportion of PrxI molecules with CYP2E1 at the cytosolic side of the ER membrane. We now show that pyrazole induces hyperoxidation of the mitochondrial enzyme PrxIII, but not that of PrxI, in mouse liver, suggesting that ROS are predominantly produced by mitochondria in the liver of pyrazole-injected mice. The pronounced oxidative damage induced by pyrazole in mice lacking either Srx or PrxIII indicated that the concerted action of these enzymes is important for protection against the pyrazole-induced oxidative stress.
Results
Pyrazole up-regulates Srx protein and mRNA in mouse liver via an Nrf2-dependent pathway An intraperitoneal injection of mice with pyrazole at doses of 75, 150, or 300 mg/kg resulted in a marked increase in the amount of Srx protein in the liver measured 18 h later by immunoblot analysis, with this effect being maximal at the dose of 150 mg/kg (Supplementary Fig. S1 ; Supplementary Data are available online at www.liebertonline.com/ars). The abundance of Srx protein in the liver was increased *17-fold by an injection of pyrazole at 150 mg/kg (Fig. 1A, B) . Reverse transcription (RT) and real-time polymerase chain reaction (PCR) analysis also showed that pyrazole induced an *22-fold increase in the amount of Srx mRNA in the liver (Fig. 1C ). An immunohistochemical analysis revealed that Srx was localized around the central vein of the liver in pyrazoleinjected mice (Fig. 1D) . Immunoreactivity was detected in the cytoplasm and the nucleus (Fig. 1D) , and the presence of a small fraction of Srx in the nucleus was confirmed by immunoblot analysis after subcellular fractionation (Fig. 1E) .
Transcription of the Srx gene is regulated through a cisacting element antioxidant-responsive element (ARE) that is activated by the binding of nuclear factor erythroid 2-related factor 2 (Nrf2) or activator protein-1 (AP-1). We previously showed that induction of Srx in the mouse liver in response to ethanol feeding is predominantly mediated via an Nrf2 pathway (2) . We, therefore, examined whether the same pathway mediates the pyrazole-induced expression of Srx with the use of Nrf2 knockout (Nrf2 -/ -) mice (Supplementary Fig. S2A ). The pyrazole-induced expression of Srx at both protein ( Fig. 2A, B ) and mRNA ( Supplementary Fig. S2B ) levels was greatly attenuated in Nrf2
-/ -mice compared with that in wild-type animals, suggesting that Nrf2 plays a key role in this process. However, the fact that pyrazole-induced Srx expression was not totally abolished in the liver of Nrf2
-/ -mice suggested that other transcription factors such as AP-1 may contribute to the transcriptional activation of the Srx gene by pyrazole.
To determine whether the induction of Srx expression by pyrazole depends on CYP2E1 induction, we examined the effect of an earlier injection of mice with chlormethiazole, which inhibits CYP2E1 expression. Chlormethiazole attenuated the pyrazole-induced increase in the amount of CYP2E1 in the liver by *90% (Fig. 2C, D) , whereas it inhibited the pyrazoleinduced up-regulation of Srx by *40% (Fig. 2C, E) . These results suggested that oxidative stress resulting from increased CYP2E1 expression is responsible, in part, for the induction of Srx expression by pyrazole. The role of oxidative stress is supported by the fact that a preinjection of N-acetyl-L-Cys significantly attenuated the expression levels of Srx protein and mRNA in the livers of pyrazole-treated mice. (Fig. 2F-H ).
Pyrazole elicits selective accumulation of PrxIII-SO 2 in the liver of Srx-deficient mice
We next examined the effect of pyrazole on the hyperoxidation of 2-Cys Prxs in the liver of wild-type and Srx knockout (Srx -/ -) mice by immunoblot analysis with antibodies that recognize a specific sequence surrounding the C P -SO 2 H moiety (37) . Given that the active site sequence is the same for 2-Cys Prxs (PrxI to IV) and that the sizes of PrxI and PrxII are identical, the sulfinic forms of PrxI and PrxII cannot be differentiated by immunoblot analysis. However, the sizes of PrxI/II, PrxIII, and PrxIV are sufficiently different for the discrimination by such an analysis. A pyrazole injection induced an approximately threefold increase in the amount of sulfinic PrxIII (PrxIII-SO 2 ) in the liver of wild-type mice (Fig.  3A, B) . The intensity of the PrxIII-SO 2 band was slightly greater for the liver of Srx -/ -mice than for that of Srx
mice before pyrazole treatment, and pyrazole induced an approximately fourfold increase in the intensity of this band in Srx -/ -mice ( Fig. 3A, B ). The extent of PrxIII hyperoxidation was evaluated further by two-dimensional (2D) polyacrylamide gel electrophoresis (PAGE) followed by immunoblot analysis (Fig. 3C ). Hyperoxidation of a Cys residue induces an acidic (leftward) shift in the position of proteins on 2D gels. The intensities of PrxIII spots suggest that 20% to 30% of PrxIII was hyperoxidized in the liver of pyrazole-treated Srx -/ -mice. The amount of PrxI/II-SO 2 in the liver was not affected by either a pyrazole injection or Srx ablation alone, but it was slightly increased by pyrazole treatment in Srx -/ -mice (Fig.  3A) . Neither a pyrazole injection nor Srx ablation affected the expression levels of PrxI to IV (Fig. 3A) . The amounts of glutathione peroxidase (Gpx), catalase, Zn-and Cu-dependent superoxide dismutase (SOD), and Mn-dependent SOD were also not affected by pyrazole treatment or Srx ablation (Fig. 3D) .
Pyrazole increases CYP2E1 abundance in mitochondria to a greater extent than in ER and induces Srx translocation to both mitochondria and the ER Both ethanol and pyrazole increase the abundance of CYP2E1 in the ER and mitochondria of rat liver (4, 29, 35) . We find, however, that pyrazole induced the hyperoxidation of PrxIII but not that of PrxI and II in the liver. We, therefore, investigated whether the abundance of CYP2E1 in hepatic mitochondria might be increased to a greater extent than that in microsomes in pyrazole-injected mice. Liver homogenates prepared from pyrazole-treated mice were subjected to subcellular fractionation, and the abundance of CYP2E1 in the total homogenate, microsomal fraction, and mitochondrial fraction was examined by immunoblot analysis. The fidelity of the subcellular fractionation was confirmed by immunoblot analysis with antibodies to the 78-kDa glucose-regulated protein (GRP78, an ER marker) and those to cytochrome c + / + or Srx -/ -mice with saline ( -) or pyrazole (150 mg/ kg) were subjected to an immunoblot analysis with antibodies to Srx, to hyperoxidized 2-Cys Prxs (Prx-SO 2 ), to PrxI to IV, or to b-actin. A total lysate (5 lg of protein) of NIH 3T3 cells that had been treated with 100 lM H 2 O 2 for 10 min was used as a positive control for hyperoxidized forms of PrxI/II and III. Data are representative of three independent experiments. (B) Densitometric analysis of PrxIII-SO 2 abundance in immunoblots similar to those in (A). Data are means -SD and are expressed relative to the normalized value for salineinjected Srx + / + mice. *p < 0.05 versus pyrazole-injected Srx + / + mice. (C) Liver homogenates (250 lg of protein) prepared from mice treated as in (A) were subjected to twodimensional polyacrylamide gel electrophoresis followed by an immunoblot analysis with antibodies specific for Prx-SO 2 and PrxIII. Ox and Re indicate spots corresponding to hyperoxidized and reduced forms, respectively, of PrxIII. (D) Liver homogenates (250 lg of protein) prepared from mice treated as in (A) were subjected to an immunoblot analysis with antibodies to glutathione peroxidase (Gpx), to catalase (Cat), to Zn-and Cu-dependent superoxide dismutase (Zn/ Cu-SOD), to Mn-dependent superoxide dismutase (Mn-SOD), or to b-actin. Data are representative of three independent experiments.
oxidase IV (COXIV, a mitochondrial marker). Pyrazole treatment induced 1.4-and 3.5-fold increases in the amount of CYP2E1 in the microsomal and mitochondrial fractions, respectively (Fig. 4A, B) . A direct assay of CYP2E1 activity also indicated that pyrazole treatment increased CYP2E1 activity in the mitochondrial fraction to a greater extent than in the microsomal fraction (Fig. 4C) . In addition, pyrazole treatment significantly increased lipid peroxidation in mitochondria but not in microsomes (Fig. 4D) .
Srx is a cytosolic protein, but it translocates to the mitochondria in response to oxidative stress (3, 25) . We previously showed that Srx also translocates to the cytosolic side of the ER membrane as well as to mitochondria in the liver of ethanol-fed mice (2). We, therefore, examined the effect of pyrazole treatment on the subcellular distribution of Srx in the liver. Srx was detected in the cytosol but not in the microsomal or mitochondrial fractions of the liver of control mice, whereas it was present in all three fractions of the liver of pyrazoletreated mice (Fig. 4E) .
Pyrazole induces ER stress that results in the accumulation of Ca 2 + and ROS in mitochondria
The larger effect of pyrazole on CYP2E1 abundance in mitochondria than in ER might account, in part, for the selective hyperoxidation of PrxIII that is apparent in the liver of pyrazole-treated mice. On the other hand, the relatively small difference in the amount of CYP2E1 in liver mitochondria versus that in microsomes might not be sufficient to account for such selectivity.
Pyrazole was previously shown to induce ER stress, as evidenced by an increase in the amount of GRP78, in mouse hepatocytes (13) . We also found that the level of GRP78 was increased in the liver of pyrazole-treated mice (Supplementary Fig. S3A, B) . ER stress results in phosphorylation of the a subunit of eukaryotic initiation factor 2 (eIF2a) by doublestranded RNA-activated protein kinase-like ER kinase (PERK) (22) . Increased phosphorylation of eIF2a was also observed in the liver of pyrazole-treated mice ( Supplementary  Fig. S3A, B) . In addition, pyrazole treatment increased the hepatic abundance of mRNAs for ER stress-related proteins, including those for GRP78, TRB3 (a mammalian ortholog of Drosophila Tribbles), and ER degradation-enhancing amannosidase-like protein (EDEM; Supplementary Fig. S3C ).
The function of the ER is closely linked to that of mitochondria. These two organelles, thus, constitute a dynamic network that underlies intracellular Ca 2 + signaling. ER stress often results in the increased loading of Ca 2 + in mitochondria, and a protracted increase in the amount of Ca 2 + in the matrix of mitochondria stimulates mitochondrial metabolism and disrupts the electron transport chain, leading to the increased production of ROS (9, 15, 22) . We, therefore, investigated whether pyrazole might increase the level of Ca 2 + in the mitochondria of HeLa (human cervical cancer) and Hepa1c1c7 (mouse hepatoma) cells with the use of the mitochondrionspecific Ca 2 + indicator Rhod-2, which becomes enriched in mitochondria as a result of its positive charge. Treatment with the Ca 2 + ionophore A23187 resulted in a marked increase in Rhod-2 fluorescence, indicative of mitochondrial Ca 2 + accumulation, in both HeLa and Hepa1c1c7 cells (Fig. 5A, B) . Treatment with pyrazole also induced mitochondrial Ca 2 + accumulation, albeit at a slower rate than that observed with A23187 (Fig. 5A, B) . We then measured the effect of pyrazole on ROS production in the mitochondria with the use of MitoSox Red, a mitochondrial-specific superoxide indicator. The respiratory chain complex I inhibitor rotenone was used as a positive control for superoxide generation. Pyrazole increased mitochondrial ROS in HeLa or Hepa1c1c7 cells, and the effect was blocked by ruthenium red, an inhibitor of mitochondrial calcium transport (Fig. 5C, D) . These results suggested that pyrazole-induced ER stress might be responsible for the increase in mitochondrial ROS. Indeed, pyrazole induced ER stress, as indicated by the increased expression of GRP78 and 
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of phosphorylation of eIF2a in HeLa or Hepa1c1c7 cells ( Supplementary Fig. S4A-D) . Pyrazole also increased protein carbonylation in the mitochondria of the two cell lines (Supplementary Fig. S4E, F) .
Ablation of PrxIII or Srx exacerbates pyrazole-induced oxidative liver injury
Though mitochondria contain peroxide-eliminating enzymes such as Gpx and Prx V, *90% of mitochondrial H 2 O 2 was estimated to react with PrxIII (8) . To elucidate the role of PrxIII in the protection of the liver from pyrazole-induced oxidative injury, we generated PrxIII knockout (PrxIII -/ -) mice ( Supplementary Fig. S6 ) and examined the amount of carbonylated (oxidized) proteins in the liver of pyrazoletreated PrxIII + / + and PrxIII -/ -mice. Carbonylated proteins were detected by derivatization of the carbonyl group with 2,4-dinitrophenylhydrazine (DNPH) followed by immunoblot analysis with antibodies to DNPH (Fig. 6A) . Given that no protein bands were detected when DNPH was omitted from the derivatization mixture ( Supplementary Fig. S7 ), the multiple bands apparent in each lane in Figure 6A likely represent carbonylated proteins. Pyrazole increased the level of protein carbonylation in the liver of both PrxIII + / + and PrxIII -/ -mice, but a quantitative assay revealed that the extent of protein carbonylation in pyrazole-treated PrxIII -/ -mice was 3.3 times that in pyrazole-treated PrxIII + / + mice (Fig. 6B) . We next examined lipid peroxidation as revealed by detection of the markers 4-hydroxynonenal (4-HNE) and malondialdehyde (MDA). An immunohistochemical analysis showed that ablation of PrxIII markedly enhanced the pyrazole-induced formation of 4-HNE adducts in the centrilobular region of the liver of mice (Fig. 6C) . Furthermore, the amount of MDA in the liver of pyrazole-treated PrxIII -/ -mice was 2.4 times that in pyrazole-treated PrxIII + / + mice (Fig. 6D) . Pyrazole also increased the frequency of apoptotic cell death in the liver of PrxIII -/ -mice to a markedly greater extent than in that of PrxIII + / + mice (Fig. 6E, F) . Finally, we also investigated the role of Srx in protection of the liver from pyrazole-induced oxidative injury in the use of Srx -/ -mice ( Supplementary Fig. S5 ). Pyrazole induced protein carbonylation, 4-HNE adduct formation, and MDA production in the liver of Srx -/ -mice to a greater extent than in that of Srx + / + mice (Fig. 7) . The effects of Srx ablation appeared to be less pronounced than those of PrxIII ablation, however, as revealed by the 1.6-and 1.7-fold increases in BAE ET AL.
pyrazole-induced protein carbonylation (Fig. 7A, B ) and MDA formation (Fig. 7D) , respectively, compared with the corresponding values of 3.3-and 2.4-fold for PrxIII ablation.
Discussion
Pyrazole increases the abundance of CYP2E1. We have now shown that pyrazole also increases the levels of Srx protein and mRNA in the mouse liver. The availability of Nrf2 -/ -mice allowed us to show that pyrazole-induced Srx expression is largely dependent on Nrf2 function. Our results, thus, suggest that pyrazole stimulates the intracellular production of ROS by up-regulating CYP2E1 abundance, and that the generated ROS trigger the release of Nrf2 from Keap1 and its translocation to the nucleus, where it binds to the ARE in the promoter region of genes for various antioxidant proteins, including Srx, thereby activating their transcription (Fig. 8) . Although pyrazole-treated mice usually do not overt liver toxicity, pyrazole induces pronounced oxidative liver damage in Nrf2 -/ -mice (21). Such damage was attributed to the failure of these mice to induce compensatory increases in the abundance of Nrf2-regulated antioxidant enzymes such as c-glutamylcysteine synthetase, heme oxygenase-1, and glutathione S-transferase (21). Our findings now suggest that Srx is also a key target of Nrf2 that is necessary to protect the liver from pyrazole-induced injury. Srx is a cytosolic protein that is able to translocate to sites where hyperoxidized (inactivated) 2-Cys Prxs are located, thereby engaging in reactivation of the inactivated enzymes under oxidative conditions (25) . We have now shown that pyrazole treatment induced the translocation of Srx molecules to mitochondria and microsomes in the mouse liver (Fig. 8) .
Among the four members of the 2-Cys Prx subgroup, only PrxIII was found to be hyperoxidized in the liver of pyrazoletreated wild-type mice, suggesting that the rate of hyperoxidation of PrxIII in mitochondria exceeded the capacity of Srx molecules which translocated to these organelles. In contrast, PrxI, but not PrxIII, was previously found to be hyperoxidized in the liver of ethanol-fed mice (2) . Given that 2-Cys Prxs undergo hyperoxidation only when engaged in the catalytic cycle, the extent of PrxIII hyperoxidation is determined by the amount of ROS produced and the capacity of Srx to reverse the hyperoxidation. One of the major ROS sources responsible for PrxIII hyperoxidation in the liver of pyrazole-treated mice is CYP2E1, which, along with PrxIII, is present in the matrix of mitochondria (5, 7) . A small proportion of PrxI molecules in microsomes was found to be hyperoxidized in the liver of pyrazole-treated Srx -/ -mice, consistent with the notion that PrxI-SO 2 was not detected in the liver of pyrazole-treated Srx + / + mice, because the capacity of Srx located at the surface of the ER is sufficient to counteract the unavoidable hyperoxidation of PrxI. Despite the fact that both PrxI and PrxII exist in the cytosol and that PrxII is more prone to hyperoxidation than is PrxI, PrxII-SO 2 was not detected in the liver of pyrazole-treated wild-type or Srx -/ -mice, suggesting that PrxII was not engaged in ROS elimination rather than that the capacity of Srx in the cytosol was sufficient to counteract its hyperoxidation.
CYP2E1 is an abundant protein in the liver that is predominantly located in microsomes. However, a substantial amount of CYP2E1 is also present in other cellular compartments, including mitochondria (4, 23, 29) . The abundance of CYP2E1 in mitochondria and microsomes was increased 3.5-and 1.4-fold, respectively, in pyrazole-treated mice. It has been shown that mitochondrial CYP2E1 is more potent in generating ROS than the ER CYP2E1 (5, 31), probably because 
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CYP2E1 is more loosely coupled to its mitochondrial electron donor ferrodoxin compared with its ER electron donor cytochrome P450 reductase. Our observation that chlormethiazole inhibited the pyrazole-induced up-regulation of Srx by only *40% whereas it inhibited that of CYP2E1 by *90% suggested the existence of a pyrazole-induced ROS source other than CYP2E1. Pyrazole is also thought to increase ROS levels in peroxisomes, given that the peroxisomal enzymes catalase and inducible nitric oxide synthase are inhibited and upregulated, respectively, by pyrazole (21, 33) . It is not likely, however, that the ROS produced in peroxisomes are able to travel to mitochondria, thereby promoting PrxIII hyperoxidation. Another CYP2E1-independent ROS source is mitochondria themselves, which are physically and functionally linked to the ER. These two organelles constitute a dynamic network that contributes to intracellular Ca 2 + signaling. Pyrazole induces ER stress, which is known to result in Ca 2 + leakage from the lumen of the ER (9, 15, 22). The Ca 2 + released from the ER is taken up by mitochondria and becomes concentrated in the mitochondrial matrix. Indeed, with the use of the indicator Rhod-2, we have now shown that pyrazole induced Ca 2 + accumulation in the mitochondria of HeLa and Hepa1c1c7 cells. Increased Ca 2 + concentration stimulates mitochondrial ROS production through multiple mechanisms, including the activation of metabolism and the disruption of electron transport (9, 15, 22) . Mitochondrial ROS can further increase Ca 2 + release from the ER by sensitizing ER Ca 2 + -release channels (9, 15, 22) . The ER stress initiated by pyrazole, thus, triggers a positive feedback loop that results in the accumulation of Ca 2 + and ROS in mitochondria (Fig. 8) . The preferential hyperoxidationof PrxIII in pyrazole-treated mice is, therefore, attributable to the cumulative effect of the preferential induction of CYP2E1 and ER stress-derived ROS production in mitochondria.
The elimination of mitochondrial ROS by PrxIII is accompanied by PrxIII hyperoxidation, and the accumulation of inactive PrxIII results in the buildup of ROS in mitochondria. The overflow of excess ROS into the cytosol triggers Nrf2 activation (Fig. 8) and inflicts oxidative damage. Oxidative damage to the liver caused by pyrazole-induced ROS production can be assessed by the measurement of carbonylated proteins, 4-HNE adducts, and MDA (10, 14) . The antioxidant role of PrxIII was, thus, evident from our findings that pyrazole-induced protein carbonylation as well as the formation of 4-HNE adducts and MDA in the liver were markedly increased in PrxIII -/ -mice compared with wild-type mice. Increased mitochondrial production of ROS resulting from PrxIII ablation was also associated with apoptotic cell death in the liver of pyrazole-treated PrxIII -/ -mice. Ablation of Srx also potentiated pyrazole-induced oxidative damage in the liver, albeit to a lesser extent than did PrxIII ablation, indicative of the key role of Srx as the guardian of 2-Cys Prxs.
Materials and Methods

Materials
Antibodies specific for PrxI to VI and for hyperoxidized 2-Cys Prxs (Prx-SO 2 ) were obtained from Young In Frontier (Seoul, Korea). Polyclonal antibodies to Srx were previously described (37) , and a mouse monoclonal antibody to Srx was generated in house. Other antibodies were obtained from the following sources: b-actin (Sigma Aldrich, St. Louis, MO), GRP78 (Stressgen, Ann Arbor, MI), CYP2E1 (Abcam, Cambridge, UK), COXIV (Cell Signaling, Beverly, MA), 4-HNE ( JaICA, Fukuroi, Japan), p-eIF2a, eIF2a (Cell Signaling, Danvers, MA), and b-tubulin (Santa Cruz Biotechnology, Santa Cruz, CA). Pyrazole, chlormethiazole, and rotenone were obtained from Sigma Aldrich (St. Louis, MO). A23187 was obtained from Invitrogen (Carlsbad, CA). Ruthenium red was obtained from Calbiochem (San Diego, CA).
Animals and treatments
All animals were housed with a 12-h-light, 12-h-dark cycle in a temperature-controlled environment. Male C57BL/6 mice and breeding pairs of Nrf2 -/ -mice were obtained from The Jackson Laboratory (Bar Harbor, ME) and RIKEN BioResource Center (Tsukuba, Japan), respectively. Overall, 8-to 10-week-old male mice were intraperitoneally injected with pyrazole (150 mg/kg) or saline, and, 18 h later, they were anesthetized by an intraperitoneal injection of pentobarbital (50 mg/kg), and the liver was perfused with phosphatebuffered saline, excised, and cut into fragments. All procedures were approved by the Animal Care and Use Committee of the Ewha Womans University.
RT-PCR analysis
Total RNA was isolated from liver tissue with the use of the Trizol reagent (Invitrogen, Carlsbad, CA). Portions (2 lg) of the RNA were subjected to RT with random hexamer primers and with the use of an ABI cDNA synthesis kit (PE Biosystems, Foster City, CA). For verification of the genotype of Nrf2 knockout mice, the resulting cDNA (1 lg) was subjected to PCR analysis with the primers specific for Nrf2 and b-actin, as previously described (3). Real-time (quantitative) PCR analysis was performed with the use of 18S rRNA as an internal control. The primer sequences for Srx and PrxI to VI were previously described (11), as were those for TRB3, GRP78, and EDEM (16) .
Subcellular fractionation and immunoblot analysis
Liver homogenates and subcellular fractions thereof were prepared as previously described (2) . 2D gel electrophoresis and immunoblot analysis were also previously described (2) . The abundance of target proteins was quantitated by a densitometric analysis of immunoblots with NIH ImageJ software.
CYP2E1 activity assay
The CYP2E1 activity in the mitochondrial or microsomal fraction was determined as described (29) .
Statistical analysis
Unless indicated otherwise, quantitative data were presented as means -standard deviation and were analyzed with the two-tailed Student's t-test. A p-value of < 0.05 was considered statistically significant.
For additional details on Materials and Methods, please refer the Supplementary Data.
